Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Equity (2023 - 2025)

CG Oncology filings provide 3 years of Return on Equity readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2025 for CG Oncology, roughly flat from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2023 to a low of 0.0% in Q1 2024.
  • Median Return on Equity over the past 3 years was 0.0% (2025), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Equity: decreased -1bps in 2024 and later changed 0bps in 2025.
  • CG Oncology's Return on Equity stood at 0.0% in 2023, then crashed by -133bps to 0.0% in 2024, then tumbled by -61bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.